The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 31, 2017

Filed:

Mar. 10, 2008
Applicants:

Steve A. Herweck, Nashua, NH (US);

Joseph Ferraro, Londonderry, NH (US);

Paul Martakos, Pelham, NH (US);

Theodore Karwoski, Hollis, NH (US);

Anthony Richard Horton, Manchester, NH (US);

Inventors:

Steve A. Herweck, Nashua, NH (US);

Joseph Ferraro, Londonderry, NH (US);

Paul Martakos, Pelham, NH (US);

Theodore Karwoski, Hollis, NH (US);

Anthony Richard Horton, Manchester, NH (US);

Assignee:

Atrium Medical Corporation, Merrimack, NH (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61L 31/10 (2006.01); A61F 2/00 (2006.01); A61L 31/14 (2006.01); A61F 2/06 (2013.01);
U.S. Cl.
CPC ...
A61L 31/10 (2013.01); A61F 2/0063 (2013.01); A61L 31/145 (2013.01); A61F 2/06 (2013.01); A61F 2250/0067 (2013.01);
Abstract

A barrier device is formed of a barrier component that can exhibit anti-inflammatory properties, non-inflammatory properties, and/or adhesion-limiting properties, as well as generate a modulated healing effect on injured tissue. The barrier component can be a non-polymeric cross-linked gel derived at least in part from a fatty acid compound, and may include a therapeutic agent. The barrier device can have anchoring locations to provide an area on the barrier device to interface with an anchoring mechanism. The anchoring locations can include openings and/or anchor elements. The barrier device can also include truss structures that provide additional strength to the barrier component. The barrier device is implantable in a patient for short term or long term applications, and can include controlled release of the therapeutic agent.


Find Patent Forward Citations

Loading…